Novartis : provides update on production of radioligand therapy medicines

Novartis has temporarily suspended production of Lutathera® and Pluvicto™/ 177Lu-PSMA-617 at facilities in Ivrea, Italy and Millburn, New Jersey

... | May 5, 2022

Related Keywords

Millburn ,New Jersey ,United States ,Zaragoza ,Baja California ,Mexico ,Italy ,Ivrea ,Piemonte ,Canada ,Spain ,America ,Isabella Zinck ,Rachel Levine ,Nicole Zinsli Somm ,Samir Shah ,Julie Masow ,Parag Mahanti ,Sloan Simpson ,Alina Levchuk ,Exchange Commission ,Twitter ,Novartis Us External Communications ,Novartis External Communications ,Novartis ,Accelerator Applications ,Novartis Ag Stock Exchange ,News ,Information ,Press Release ,Gas ,Emporarily ,Uspended ,Production ,F ,End ,It ,Facilities ,N ,Ew Novn Ch0012005267 ,